Archive

Year: 2017

All Year: 2017 Articles

Newest first · Page 370

Tocagen Announces Potential Pricing for IPO

Tocagen expects to price more than 7 million shares in the range of $10 to $12 apiece for an initial public offering valued up to about $100 million.

Chris Lange · 10 years ago

5 Unusual Analyst Upgrades From Monday

While many analyst calls are basic upgrades and downgrades, there are often some very unusual upgrades or positive calls for big upside to the analyst price targets. Here are five unusual upgrades and positive…

Jon C. Ogg · 10 years ago

Ford’s March Car Sales Tanked

Ford's March sales dropped 7.2% as passenger car sales tumbled by more than 25%. Even the company's top-selling F-Series pickups couldn't make up the difference.

Paul Ausick · 10 years ago

Jefferies Even More Bullish on Top Banks

One key analyst thinks that first-quarter results from banks will not be mind-blowing, but instead believes estimates are still biased upward as more rate hikes get built in, deposit betas remain low and credit…

Chris Lange · 10 years ago

Cloudera Files for IPO

Cloudera has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange · 10 years ago

Why NovoCure Shares Are Skyrocketing

NovoCure saw its shares skyrocket early on Monday after the firm provided an update for its late-stage cancer trial.

Chris Lange · 10 years ago